Core Scientific, Inc. (CORZ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
CoreWeave last year tried to acquire Core Scientific for $5.75 a share, which at the time valued the business at north of $1 billion. Core Scientific rejected the proposal as too low.
Core Scientific is executing a successful transition from Bitcoin mining to high-density AI colocation infrastructure. Take-or-pay agreements confirmed, eliminating concerns about cancellation risk or dependency on fluctuating AI demand. Enterprise AI demand emerging as a major growth driver; pipeline includes 50–100MW prospects beyond CoreWeave.
Core Scientific, Inc. (NASDAQ:CORZ ) Q1 2025 Results Conference Call May 7, 2025 4:30 PM ET Company Participants Jon Charbonneau - Vice President, Investor Relations Adam Sullivan - CEO, President & Director Matt Brown - Chief Operating Officer Jim Nygaard - Chief Financial Officer Conference Call Participants Joe Flynn - Compass Point Research Brett Knoblauch - Cantor Fitzgerald Darren Aftahi - Roth MKM Nick Giles - B Riley John Todaro - Needham & Company Kevin Dede - H.C. Wainwright Paul Golding - Macquarie Capital Bill Papanastasiou - Keefe, Bruyette, & Woods Operator Good day, ladies and gentlemen, and welcome to Core Scientific First Quarter Fiscal Year 2025 Earnings Conference Call.
Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.19 per share a year ago.
Core Scientific, Inc. (CORZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Scientific, Inc. (CORZ) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Core Scientific's pivot from bitcoin mining to AI infrastructure, securing $10.2 billion in long-term contracts, offers a stable revenue stream and significant growth potential. The recent stock price decline due to speculative concerns presents a compelling investment opportunity, with a conservative valuation indicating a 64% upside. CoreWeave's $12 billion contract with OpenAI reaffirms strong demand for AI infrastructure, mitigating fears over Microsoft's commitment and reinforcing CORZ's business model.
Core Scientific shares are undervalued due to market volatility and false rumors about Microsoft canceling leases with CoreWeave, presenting a significant investment opportunity. CORZ has $10.2B in future contracted revenue with high margins and management expects critical IT load to more than double by 2028. Positive developments include issuing $1B in convertible notes, completing significant contracts, and insider buying, indicating confidence in the company's future.
Core Scientific, Inc. (NASDAQ:CORZ ) Q4 2024 Earnings Call Transcript February 26, 2025 4:30 PM ET Company Participants Jon Charbonneau - Vice President, Investor Relations Adam Sullivan - CEO, President & Director Denise Sterling - Chief Financial Officer Conference Call Participants Darren Aftahi - Roth MKM Jon Petersen - Jefferies Joe Flynn - Compass Point Research Brett Knoblauch - Cantor Fitzgerald Greg Lewis - BTIG George Sutton - Craig Hallum Stephen Glagola - JonesTrading John Todaro - Needham & Company Kevin Dede - H.C. Wainwright Nick Giles - B Riley Joseph Vafi - Canaccord Genuity Bill Papanastasiou - Stifel Rosemarie Sison - Odeon Operator Greetings.
Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.20 per share a year ago.
DeepSeek's artificial intelligence announcement triggered a sizable sell-off in bitcoin miners this week. One of the hardest hit among them was Core Scientific Inc. In just the last five days, the Core Scientific stock has slumped down around 25%.